David Rosenbaum
Corporate Officer/Principal at ARDELYX, INC.
Net worth: 4 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Elizabeth Grammer | F | 60 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | 20 years |
Justin Renz | M | 52 | 4 years | |
David Mott | M | 58 | 15 years | |
Mike Raab Raab | M | 59 | 15 years | |
Robert Felsch | M | - | 4 years | |
William Bertrand | M | 59 | 9 years | |
Richard Rodgers | M | 57 | 10 years | |
Robert Blanks | M | 64 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | 17 years |
Jan Lundberg | M | 71 | 6 years | |
Onaiza Cadoret-Manier | F | 60 | 4 years | |
Robert Bazemore | M | 56 | 8 years | |
Laura Williams | M | 61 | 4 years | |
Muna Bhanji | F | 61 | 3 years | |
Caitlin Lowie | F | - | 2 years | |
Susan Rodriguez | F | 60 | 4 years | |
Charon Spencer | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark E. Kaufmann | M | 56 | 9 years | |
Peter G. Schultz | M | 67 | 8 years | |
Dominique Charmot | M | 69 | 7 years | |
Fran M. Stoller | F | 65 |
University of Pennsylvania
| 7 years |
Abdi Mahamedi | M | 60 |
University of Pennsylvania
| 5 years |
Muffy Carter | F | 71 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA.
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 10 years |
John Perrachon | M | 69 |
University of Pennsylvania
| 7 years |
David Collier | M | 61 | - | |
Alan D. Berkowitz | M | - |
University of Pennsylvania
| 17 years |
George Prokopakis | M | - |
University of Pennsylvania
| 5 years |
Justin Yuan Shi | M | - |
University of Pennsylvania
| 5 years |
Jean M. Fréchet | M | - | 7 years | |
Stephen C. Koval | M | - |
University of Pennsylvania
| 3 years |
Geoffrey A. Block | M | 58 | 4 years | |
Jeffrey W. Jacobs | M | 61 | 13 years | |
Carlo Andrea Bollino | M | 69 |
University of Pennsylvania
| 4 years |
John D. Hogoboom | M | - |
University of Pennsylvania
| 7 years |
Fritz Thomas | M | - |
University of Pennsylvania
| 6 years |
Annalisa Jenkins | M | 58 | 5 years | |
Keith Santorelli | M | - | - | |
Paul Hursky | M | - |
University of Pennsylvania
| 6 years |
Awang Adek bin Hussin | M | 70 |
University of Pennsylvania
| 4 years |
Edwin R Kraft | M | - |
University of Pennsylvania
| 5 years |
Kimia Keshtbod | F | - | - | |
Timothy Noyes | M | 62 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA.
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 10 years |
Andy Attinson | M | - |
University of Pennsylvania
| 6 years |
Leif-Olof Fager | M | - |
University of Pennsylvania
| 8 years |
Dan I. DeWolf | M | 67 |
University of Pennsylvania
| 7 years |
Wayne A. Palladino | M | 65 |
University of Pennsylvania
| 7 years |
Paul Mellett | M | 68 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | 3 years |
Lance J. Graber | M | 62 |
University of Pennsylvania
| 8 years |
Mark B. Skaletsky | M | 75 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | 7 years |
Donald Martin Gilbert | M | - |
University of Pennsylvania
| 6 years |
Gordon Ringold | M | 73 | 7 years | |
Philip Erlanger | M | 68 |
University of Pennsylvania
| 6 years |
Sang-Hoon Lee | M | 69 |
University of Pennsylvania
| 3 years |
Julio E. Vega | M | - |
University of Pennsylvania
| 7 years |
Andy Rachleff | M | 66 |
University of Pennsylvania
| 4 years |
Mark R. Osherow | M | - |
University of Pennsylvania
| 4 years |
J. Golub | M | - |
University of Pennsylvania
| 4 years |
Steven Schwarz | M | - |
University of Pennsylvania
| 4 years |
Kyu-Hong Yu | M | 66 |
University of Pennsylvania
| 4 years |
Kathy Smith | F | - |
University of Pennsylvania
| 2 years |
Tod Nasser | M | - |
University of Pennsylvania
| 4 years |
Scott H. Kintzing | M | 71 |
University of Pennsylvania
| 4 years |
George Murnane | M | 67 |
University of Pennsylvania
| 4 years |
Howard E. Winklevoss | M | - |
University of Pennsylvania
| 12 years |
Brian Sullivan | M | - |
University of Pennsylvania
| 3 years |
Kathleen H. McGuan | F | - |
University of Pennsylvania
| 2 years |
Nathalie Joannes | F | - |
University of Pennsylvania
| 3 years |
John Petro | M | - |
University of Pennsylvania
| 3 years |
David C. Gottlieb | M | - |
University of Pennsylvania
| 4 years |
Madeleine Schachter | F | - |
University of Pennsylvania
| 4 years |
Philip R. Guys | M | 61 |
University of Pennsylvania
| 4 years |
John D. Stanley | M | 66 |
University of Pennsylvania
| 3 years |
Robert F. Cusumano | M | 67 |
University of Pennsylvania
| 3 years |
Richard Diamond | M | - |
University of Pennsylvania
| 4 years |
Carl A. Schulz | M | - |
University of Pennsylvania
| 4 years |
Kevin Xavier Reynolds | M | - |
University of Pennsylvania
| 2 years |
Ronald E. Nyman | M | - |
University of Pennsylvania
| 4 years |
Merle Symes | M | 72 |
University of Pennsylvania
| 2 years |
David M. Wilf | M | - |
University of Pennsylvania
| 4 years |
Fred A. Shabel | M | - |
University of Pennsylvania
| 5 years |
Scott A. McCallister | M | - |
University of Pennsylvania
| 2 years |
Faith Rosenfeld | F | - |
University of Pennsylvania
| 2 years |
Daniel M. Perlman | M | 67 |
University of Pennsylvania
| 4 years |
Ronald S. Safer | M | - |
University of Pennsylvania
| 4 years |
Ken Leech | M | - |
University of Pennsylvania
| 6 years |
Philip Timon | M | - |
University of Pennsylvania
| 4 years |
Jonathan Haddon | M | - |
University of Pennsylvania
| 4 years |
Mark A. Baker | M | 63 |
University of Pennsylvania
| 4 years |
Walter J. Mostek | M | - |
University of Pennsylvania
| 3 years |
Morris F. DeFeo | M | - |
University of Pennsylvania
| 4 years |
Michael Miller | M | - |
University of Pennsylvania
| 4 years |
Gerry D. Koumatos | M | - |
University of Pennsylvania
| 5 years |
James M. Pachence | M | - |
University of Pennsylvania
| 3 years |
James Edward Hahn | M | - |
University of Pennsylvania
| 4 years |
Charles F. Gauvin | M | - |
University of Pennsylvania
| 4 years |
Anne Welsh McNulty | F | - |
University of Pennsylvania
| 2 years |
Steven M. Cohen | M | - |
University of Pennsylvania
| 4 years |
Robin L. Cohen | F | - |
University of Pennsylvania
| 4 years |
Andy A. Ellner | M | - |
University of Pennsylvania
| 3 years |
Bryan Evans Gordon | M | - |
University of Pennsylvania
| 4 years |
Jim René | M | - |
University of Pennsylvania
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Rosenbaum
- Personal Network